Those of us in the US who have been overwhelmed lately by overly
excited health care stories in the media look fondly across the Pond. We are
confident that we can find a much calmer discourse about these issues in the UK. After all, a single payer system, well
established, and held in fond regard by the populace can’t be very
controversial. Well maybe.
Here’s a synopsis of one
day’s news coverage about the NHS from The
Times and The Daily Telegraph. Make sure you read all the way to the last one. My head is spinning.
•A hospital trust
whose staff were allegedly forced to alter waiting times of cancer patients has
been put in “special measures” by Monitor, the health regulator. An “improvement director” will be appointed
by Monitor to ensure the [Colchester Hospital University NHS Foundation Trust]
turns itself around. “The leadership of the trust will be reviewed as part of
our scrutiny of the trust’s governance arrangements and, if necessary, further
regulatory action will be taken.”
•Hundreds of teenage
girls have had genital cosmetic surgery on the NHS, prompting doctors to call
for an end to state-funded “designer vaginas.” Internet pornography has driven
a five-fold increase in female genital surgery in the past decade and more than
2,000 women a year now have the procedure on the NHS. Ruptures are reported in up to a third of
cases and NHS surgeons report seeing women with complications caused by surgery
in the private sector. There is no evidence that the surgery improves women’s
lives.
•Nine of the world’s
biggest pharmaceutical companies have warned that innovative new medicines are
being blocked from use in the NHS and are calling for an overhaul of the
commissioning process. They said that,
since 2005, the National Institute for Health and Clinical Excellence (NICE),
the body that selects drugs for use in the NHS, has approved “fewer than
one-in-three medicines” and needs to be given a new mandate to make the UK a
world leader in innovation. In a statement, NICE said the companies had “wildly
underestimated” the proportion of drugs approved and it “supports more than
80pc of the drugs appraised. The NHS needs to be confident that the treatments
it buys with its increasingly stretched resources are both clinically and cost
effective.”
•Wider use of statins
will have minimal benefit and could needlessly expose thousands to severe
side-effects, a leading doctor has claimed following a change in US
prescription guidelines. Dr. Aseem Malhotra, a cardiology specialist registrar
at Croyden University Hospital, south London, said he would be “disturbed” if
Britain followed America in changing prescription guidelines to widen use of
statins. Side-effects experienced by up to one in five patients include severe
muscle aches, memory disturbances, sexual dysfunction, cataracts and diabetes.
•And here are two presentations of the same story:
The Daily Telegraph
story, headlined, “Return of ‘proper family doctors:’”
A new contract for GPS
will see the return of “proper family doctors” responsible for out-of-hours
care for the elderly, Jeremy Hunt, the Health Secretary, announced today. The deal agreed with the British Medical
Association reverses changes introduced by Labour that allowed family doctors to
abandon responsibility for care outside office hours. Mr. Hunt says that the
changes are crucial because the failure to care for older patients is behind a
crisis in NHS emergency care, with millions of patients admitted to hospital
because they cannot get help in time from their GPs.
The Times headline was, “GPs told to reveal
their pay:”
Family doctors will
have to reveal their salaries from next year, under changes to be outlined
today by the Health Secretary. Jeremy Hunt said that he had secured the
agreement of the British Medical Association to publish the pay of GPs, in
return for waiving a series of targets and handing nearly £300 million of
performance-related pay directly to doctors.
[Hunt said,]
“Transparency is always uncomfortable. People will get used to it, but it needs
to be linked to outstanding performance.”
Both stories talk about the elimination of 40 percent of GP
performance targets. Here’s the
Telegraph quote:
Under the targets
framework, doctors have been paid for improving their handwriting, or ensuring
staff undergo training, or for asking their patients how often they take part
in activities such as DIY, cooking or gardening.
And the Times quotes Dr. Chaand Nagpaul, chairman of the
BMA’s GP committee, applauding the change as:
Freeing up resources
for GPs to use their clinical judgment—not a checklist—when treating their
patients.
And finally:
•GPs are seeing up to
ten patients a day who are lonely rather than ill, according to research. Three
quarters of GPs questioned said it was usual to see between one and five
patients a day in their surgeries primarily because they were desperate for
human contact. However, some doctors had even higher rates of patients
suffering loneliness with one in ten saying that they saw up to ten patients a
day who came in for the company. Half said they were not confident about
whether they could help their lonely patients.
I think the last anecdote is just as true here as overseas. My father used to tell me there was a significant portion of his patients just wanting someone to talk to. He always liked the personal contact so had no problem with it, in fact he rather enjoyed it, but I don't know that modern training and evidence based medicine has an algorithm designed for symptoms of loneliness.
ReplyDeleteIn the military, prescriptions are "free" if they are picked up at the pharmacy (versus co-pay for mail-order). Many patients will choose to come to the pharmacy even though they have to drive long distances and wait a long time for the prescription because it is a social occasion for them (they also take time to eat in the cafeteria).
ReplyDelete